SCHEMBL7216130

SCHEMBL7216130

O=C(Nc1ccn(CCCN2CCC2)n1)c1c[nH]c2c1-c1ncccc1CCC2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCK P35557 1/20 0.36
MET P08581 2/20 0.34
NAMPT P43490 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
S100A4 P26447 1/20 0.32
IGF1R P08069 2/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
CHRM1 P11229 1/20 0.31
CHRM3 P20309 1/20 0.31
BUB1 O43683 1/20 0.31
NR3C1 P04150 1/20 0.31
DRD2 P14416 1/20 0.30
DRD3 P35462 1/20 0.30
KDM4E B2RXH2 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2D6 P10635 1/20 0.30
ALOX15 P16050 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
ROCK2 O75116 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7217066 0.95 GCK (0.40) GCKMETNPSR1IGF1RCHRM2
SCHEMBL7218419 0.93 GCK (0.40) GCKMETNAMPTNPSR1IGF1R
SCHEMBL7223214 0.89 NPSR1 (0.34) GCKNPSR1IGF1RCHRM2CHRM4
SCHEMBL7218337 0.88 GCK (0.33) GCKNPSR1CHRM2CHRM4CHRM1
SCHEMBL7223026 0.87 GCK (0.33) GCKNPSR1CHRM2CHRM4CHRM1
SCHEMBL7222958 0.87 NPSR1 (0.34) GCKNAMPTNPSR1CHRM2CHRM4
SCHEMBL7221707 0.86 GCK (0.32) GCKNPSR1
SCHEMBL7223491 0.86 GCK (0.32) GCKNPSR1KDM4E
SCHEMBL7222707 0.86 GCK (0.34) GCKNPSR1CHRM2CHRM4CHRM1
SCHEMBL7223193 0.86 PIM1 (0.32) GCKNPSR1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6653471-B2 Tricyclic heteroaromatic compounds containing pyrrole ring; central nervous system disorder treatment; side effect reduction NEUROGEN CORPORATION 2003-11-25 US disclosed